Guardion Health Sciences Inc. (GHSI) NASDAQ
$7.98 (0.30) (-3.62%)
Market Cap: $10.63M
As of 04/24/24 04:00 PM EDT. Market closed.
Guardion Health Sciences Inc. (GHSI)
NASDAQ
$7.98
(0.30) (-3.62%)
Market Cap: $10.63M
As of 04/24/24 04:00 PM EDT. Market closed.
Add to Portfolio
by applying the latest science, technology and research, guardion health sciences (ghs) has positioned itself to address the escalating demand for solutions that promise to improve life-diminishing health problems facing the aging baby boomer generation. guardion health sciences is dedicated to applying a scientific discipline and pharmaceutical approach to the development of safe, standardized ... read more
COMPANY PROFILE
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
Full Time Employees
18
Address
15150 Avenue of Science Ste 200, California, San Diego, 92128-3416.
PRICE CHART FOR GUARDION HEALTH SCIENCES INC
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
-
Previous Close
$8.28
Days Range
$7.80 - $8.19
52 week range
$5.01 - $10.75
Volume
7,546
Avg. Volume (30 days)
12,838
Market Cap
$10.63M
Dividend Yield
-
P/E
67.28
Shares Outstanding
1,284,156
Open
-
Previous Close
$8.28
Days Range
$7.80 - $8.19
52 week range
$5.01 - $10.75
Volume
7,546
Avg. Volume (30 days)
12,838
Market Cap
$10.63M
Dividend Yield
-
P/E
67.28
Shares Outstanding
1,284,156
FINANCIAL STATEMENTS FOR GUARDION HEALTH SCIENCES INC
LOADING...
Open in: 
Open in:
INSIDER TRANSACTIONS FOR GUARDION HEALTH SCIENCES INC
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| Radoff Bradley Louis | 10% Owner | Jan 10, 2023 | Buy | $7.60 | 31,900 | 242,353 | 217,900 | Jan 11, 2023, 05:11 PM |
| Radoff Bradley Louis | 10% Owner | Jan 09, 2023 | Buy | $6.88 | 84,821 | 583,487 | 186,000 | Jan 11, 2023, 05:11 PM |
| Scholtes Bret | CEO and President | Jan 06, 2022 | Option Exercise | $0.65 | 37,175 | 24,164 | 294,980 | Jun 16, 2022, 04:10 PM |
| Scholtes Bret | CEO and President | Aug 31, 2021 | Buy | $1.23 | 5,500 | 6,760 | 179,484 | Sep 01, 2021, 04:20 PM |
| Scholtes Bret | CEO and President | Aug 30, 2021 | Buy | $1.26 | 4,500 | 5,656 | 173,984 | Sep 01, 2021, 04:20 PM |
| Gagliano Donald A | Director | Aug 30, 2021 | Buy | $1.25 | 5,000 | 6,250 | 27,750 | Aug 31, 2021, 04:20 PM |
| Gagliano Donald A | Director | Apr 09, 2019 | Option Exercise | $3.92 | 1,500 | 5,887 | 136,500 | Aug 31, 2021, 04:15 PM |
| WEINGARTEN ROBERT N | Director | Aug 20, 2021 | Option Exercise | $1.14 | 10,000 | 11,400 | 118,750 | Aug 23, 2021, 06:10 AM |
| Evans David W | Chief Science Officer | Oct 30, 2019 | Option Exercise | $0.33 | 2,000 | 664 | 1,544,500 | Oct 30, 2019, 03:00 PM |
| Evans David W | Chief Science Officer | Aug 15, 2019 | Option Exercise | $0.44 | 20,000 | 8,800 | 1,522,500 | Aug 22, 2019, 04:52 PM |
| Gagliano Donald A | Director | Apr 09, 2019 | Option Exercise | $3.92 | 1,500 | 5,887 | 136,250 | Apr 17, 2019, 04:40 PM |
| Goldstone Mark | Director | Apr 08, 2019 | Option Exercise | $3.53 | 300 | 1,060 | 525,300 | Apr 10, 2019, 04:14 PM |
| Evans David W | Chief Scientific Officer | Apr 09, 2019 | Option Exercise | $4.00 | 6,500 | 26,000 | 1,502,500 | Apr 10, 2019, 04:11 PM |
| WEINGARTEN ROBERT N | Director | Apr 09, 2019 | Option Exercise | $4.00 | 2,500 | 10,000 | 652,500 | Apr 10, 2019, 04:08 PM |
| FAVISH MICHAEL | Chief Executive Officer | Apr 09, 2019 | Option Exercise | $4.00 | 1,000 | 4,000 | 1,000 | Apr 10, 2019, 04:05 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
| Owner | Relationship | Date | Value($) |
| Radoff Bradley Louis | 10% Owner | 01/10/2023 | 242,353 |
| Radoff Bradley Louis | 10% Owner | 01/09/2023 | 583,487 |
| Scholtes Bret | CEO and President | 01/06/2022 | 24,164 |
| Scholtes Bret | CEO and President | 08/31/2021 | 6,760 |
| Scholtes Bret | CEO and President | 08/30/2021 | 5,656 |
| Gagliano Donald A | Director | 08/30/2021 | 6,250 |
| Gagliano Donald A | Director | 04/09/2019 | 5,887 |
| WEINGARTEN ROBERT N | Director | 08/20/2021 | 11,400 |
| Evans David W | Chief Science Officer | 10/30/2019 | 664 |
| Evans David W | Chief Science Officer | 08/15/2019 | 8,800 |
| Gagliano Donald A | Director | 04/09/2019 | 5,887 |
| Goldstone Mark | Director | 04/08/2019 | 1,060 |
| Evans David W | Chief Scientific Officer | 04/09/2019 | 26,000 |
| WEINGARTEN ROBERT N | Director | 04/09/2019 | 10,000 |
| FAVISH MICHAEL | Chief Executive Officer | 04/09/2019 | 4,000 |
Load More Insider Transactions
FUNDS WITH A POSITION IN GUARDION HEALTH SCIENCES INC
| Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
|---|---|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC | 38,020 | 0.00031% | -4.28% | Other |
| BLACKROCK INC. | 10,030 | 0% | No change | Other |
CHANGE IN SHARES OUTSTANDING FOR GUARDION HEALTH SCIENCES INC
STOCK BUYBACKS FOR GUARDION HEALTH SCIENCES INC
Load More
Period of Report: 12/31/2023
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
09/30/2023
-0.77%
1Q
06/30/2023
-0.29%
2Q
03/31/2023
-0.29%
3Q
12/31/2022
2.55%
4Q
09/30/2022
2.57%
5Q
06/30/2022
2.65%
6Q
03/31/2022
61.38%
7Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR GUARDION HEALTH SCIENCES INC
LOADING...